Novo Nordisk Pharmatech A/S is the leading worldwide supplier of pharma grade quaternary ammonium compounds (Quats) and recombinant Insulin for cell growth media for the pharma, biopharma and personal care industries. Both are manufactured to cGMP standards, and in both product areas the company has distinguished itself for: Global regulatory compliance Consistent high quality Extensive regulatory documentation Continuous availability Secure global supply chain High levels of service and support Novo Nordisk Pharmatech’s quality system meets DS/EN ISO 9001 and ICH Guide Q7 for APIs. In-process samples, as well as finished products, are carefully analysed in a modern, well-equipped laboratory. Fast and reliable services in documentation, analysis and manufacturing – as well as the ability to meet or exceed local and international regulatory requirements – have been the keys to securing customer satisfaction. The company’s delivery and stock policy is designed to meet the most demanding and urgent requirements of its customers, worldwide. Novo Nordisk Pharmatech A/S has attracted an extensive roster of leading pharma and biopharma manufacturers through unsurpassed product quality, manufacturing and quality control, regulatory documentation, precision delivery and a comprehensive risk mitigation.

Registered Capital:  

Registered Address:  

Company Type:  Production

Business Scope: